Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.260
-0.140 (-10.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 52 | 71 | 60 | 121 | 159 | - |
| Market Cap Growth | -29.77% | 17.53% | -50.38% | -23.75% | - | - |
| Enterprise Value | 37 | 66 | 46 | 105 | 159 | - |
| Last Close Price | 1.26 | 2.73 | 2.35 | 5.20 | 6.82 | - |
| PB Ratio | 3.46 | 18.57 | 5.68 | 8.06 | 7.44 | - |
| P/TBV Ratio | 2.91 | 18.57 | 5.68 | 8.06 | 7.44 | - |
| Debt / Equity Ratio | - | - | - | - | - | 0.07 |
| Quick Ratio | 17.10 | 11.87 | 10.52 | 28.39 | 82.71 | 13.53 |
| Current Ratio | 17.52 | 13.46 | 10.92 | 30.40 | 89.61 | 13.53 |
| Return on Equity (ROE) | -71.49% | -113.80% | -91.42% | -37.42% | -249.85% | - |
| Return on Assets (ROA) | -42.87% | -65.97% | -54.05% | -22.93% | -18.30% | - |
| Return on Capital (ROIC) | -46.65% | -72.06% | -57.38% | -23.41% | -18.50% | - |
| Earnings Yield | -14.81% | -11.58% | -19.48% | -5.62% | -19.00% | - |
| FCF Yield | -12.84% | -11.43% | -16.07% | -4.48% | -3.06% | - |
| Buyback Yield / Dilution | -2.48% | -2.98% | -7.41% | -71.49% | -13.44% | - |
| Total Shareholder Return | -2.48% | -2.98% | -7.41% | -71.49% | -13.44% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.